SanBio Co. Ltd. | Mutual Funds
Mutual Funds that own SanBio Co. Ltd.
JPMorgan Funds - Japan Equity Fund
698,800
1.41%
106,400
0.59%
06/30/2018
RBC Japanese Equity Fund
600,000
1.21%
-38,800
2.24%
12/31/2017
Baillie Gifford Overseas Growth Fund - Japanese Smaller Cos.
586,000
1.18%
44,900
2.13%
04/30/2018
Comgest Growth Plc - Japan
452,100
0.91%
68,300
0.15%
05/31/2018
Baillie Gifford Shin Nippon Plc
346,600
0.7%
0
2.18%
10/31/2017
JPM Asset JPM The Japan Mother Fund
226,500
0.46%
-285,099
0.48%
03/26/2018
Baillie Gifford Japan Trust Plc
225,000
0.45%
0
0.83%
10/31/2017
JPMorgan Japanese Investment Trust Plc
180,600
0.36%
0
0.54%
06/29/2018
JPMorgan Fund ICVC - Japan Fund
164,900
0.33%
39,200
0.56%
06/30/2018
AXA Framlington Japan Fund
151,000
0.3%
0
1.63%
02/15/2018
| Address |
St. Luke Tower, 28/F
Tokyo Tokyo 104
Japan
|
|
Employees
|
- |
| Website |
http://www.sanbio.jp |
| Updated |
07/08/2019 |
| SanBio Co., Ltd. engages in the development and sale of regenerative cells pharmaceuticals. It also provides regenerative therapies for neurological disorders that include stroke, traumatic brain injury, eye diseases, and Parkinson's disease. The company was founded by Keita Mori and Toru Kawanishi in February 2001 and is headquartered in Tokyo, Japan. |
